Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.
Dowling GP, Daly GR, Hegarty A, Flanagan M, Ola M, Fallon R, Cocchiglia S, Singh V, Sheehan KM, Bane F, McGrath J, Watson L, Hembrecht S, Hennessy B, Morris PG, Hill ADK, Varešlija D, Young LS.
Dowling GP, et al. Among authors: hill adk.
Cancer Commun (Lond). 2024 Dec 15. doi: 10.1002/cac2.12640. Online ahead of print.
Cancer Commun (Lond). 2024.
PMID: 39676516
No abstract available.